Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuanyu Yang

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Theranostics|March 16, 2023
KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8<sup>+</sup> T-cell-dependent antitumor immunityQi Wu, Zhou Liu, Zhijie Gao, et al.
Iscience|March 1, 2024
Inhibition of a conserved bacterial dual-specificity phosphatase confers plant tolerance to <i>Candidatus</i> Liberibacter sppHaoqi Wang, Sonia Irigoyen, Jiaxing Liu, et al.
Cell Death and Differentiation|May 11, 2021
Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancerXinye Wang, Ting Qiu, Yingying Wu, et al.
Signal Transduction and Targeted Therapy|May 28, 2021
Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROSJiao Wu, Sai-Ching Jim Yeung, Sicheng Liu, et al.
The Journal of Clinical Investigation|June 20, 2018
HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infectionFubing Li, Yang Li, Huichun Liang, et al.
Cell Death and Differentiation|January 13, 2022
YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancerDewei Jiang, Ting Qiu, Junjiang Peng, et al.
Signal Transduction and Targeted Therapy|July 8, 2025
A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growthHuichun Liang, Fubing Li, Huan Fang, et al.
International Journal of Biological Sciences|March 28, 2022
Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast CancerYanjie Kong, Wenlong Ren, Huan Fang, et al.
Oncogene|August 20, 2024
BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expressionYanjie Kong, Tianlong Lan, Luzhen Wang, et al.
Cancer Letters|March 8, 2022
A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancerGuangshi Du, Jian Sun, Zhen Li, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Theranostics|March 16, 2023
KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8<sup>+</sup> T-cell-dependent antitumor immunityQi Wu, Zhou Liu, Zhijie Gao, et al.
Iscience|March 1, 2024
Inhibition of a conserved bacterial dual-specificity phosphatase confers plant tolerance to <i>Candidatus</i> Liberibacter sppHaoqi Wang, Sonia Irigoyen, Jiaxing Liu, et al.
Cell Death and Differentiation|May 11, 2021
Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancerXinye Wang, Ting Qiu, Yingying Wu, et al.
Signal Transduction and Targeted Therapy|May 28, 2021
Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROSJiao Wu, Sai-Ching Jim Yeung, Sicheng Liu, et al.
The Journal of Clinical Investigation|June 20, 2018
HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infectionFubing Li, Yang Li, Huichun Liang, et al.
Cell Death and Differentiation|January 13, 2022
YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancerDewei Jiang, Ting Qiu, Junjiang Peng, et al.
Signal Transduction and Targeted Therapy|July 8, 2025
A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growthHuichun Liang, Fubing Li, Huan Fang, et al.
International Journal of Biological Sciences|March 28, 2022
Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast CancerYanjie Kong, Wenlong Ren, Huan Fang, et al.
Oncogene|August 20, 2024
BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expressionYanjie Kong, Tianlong Lan, Luzhen Wang, et al.
Cancer Letters|March 8, 2022
A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancerGuangshi Du, Jian Sun, Zhen Li, et al.
Pageof 8